Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms

Biotechnology and Bioengineering

Volumn 111, Issue 2, 2014, Pages 418-424

  Srinivasan, Anand ^a   Gupta, Celia Macias ^a   Agrawal, C Mauli ^a   Leung, Kai P ^b   Lopez Ribot, Jose L ^c   Ramasubramanian, Anand K ^a,c  

^a The University of Texas at San Antonio   (United States)

^b US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Biofilms; Candida albicans; Caspofungin; Drug screening; High throughput; Hydrogels; Microarray

Indexed keywords

CANDIDA; COLLAGEN; HYDROGELS; MICROARRAYS; YEAST;

ALGINATE HYDROGELS; BIOMEDICAL DEVICES; CANDIDA ALBICANS; CASPOFUNGIN; CELL ENCAPSULATIONS; DRUG SCREENING; DRUG SUSCEPTIBILITY; HIGH-THROUGHPUT;

BIOFILMS;

ALGINIC ACID; AMPHOTERICIN B; CASPOFUNGIN; COLLAGEN; FLUCONAZOLE; ANTIFUNGAL AGENT; ECHINOCANDIN; HYDROGEL;

ANIMAL CELL; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL ENCAPSULATION; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FUNGAL CELL WALL; FUNGAL STRAIN; HIGH THROUGHPUT SCREENING; HYDROGEL; NONHUMAN; DRUG EFFECTS; DRUG SCREENING; IMMOBILIZED CELL; MICROBIAL SENSITIVITY TEST; PROCEDURES;

BACTERIA (MICROORGANISMS); CANDIDA ALBICANS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CELLS, IMMOBILIZED; DRUG EVALUATION, PRECLINICAL; ECHINOCANDINS; HYDROGEL; MICROBIAL SENSITIVITY TESTS;

EID: 84890791720     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.25120     Document Type: Article

References (31)

1. Amsden B. 1998. Solute diffusion within hydrogels. Mechanisms and models. Macromolecules 31:8382-8395.
2. Bryers JD. 2008. Medical biofilms. Biotechnol Bioeng 100(1):1-18.
3. Chan AW, Neufeld RJ. 2010. Tunable semi-synthetic network alginate for adsorptive encapsulation and controlled release of protein therapeutics. Biomaterials 31(34):9040-9047.
4. Donlan RM, Costerton JW. 2002. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15(2):167-193.
5. Eschenauer G, Depestel DD, Carver PL. 2007. Comparison of echinocandin antifungals. Ther Clin Risk Manag 3(1):71-97.
6. Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D. 2003. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37(9):1172-1177.
7. Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: From the natural environment to infectious diseases. Nat Rev Microbiol 2(2):95-108.
8. Huang X, Brazel CS. 2001. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release 73:121-136.
9. Kojic EM, Darouiche RO. 2004. Candida infections of medical devices. Clin Microbiol Rev 17(2):255-267.
10. Lazzell AL, Chaturvedi AK, Pierce CG, Prasad D, Uppuluri P, Lopez-Ribot JL. 2009. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. J Antimicrob Chemother 64(3):567-570.
11. Leal-Egana A, Braumann UD, Diaz-Cuenca A, Nowicki M, Bader A. 2011. Determination of pore size distribution at the cell-hydrogel interface. J Nanobiotechnology 9:24.
12. Lee MY, Kumar RA, Sukumaran SM, Hogg MG, Clark DS, Dordick JS. 2008. Three-dimensional cellular microarray for high-throughput toxicology assays. Proc Natl Acad Sci USA 105(1):59-63.
13. Li RH, Altreuter DH, Gentile FT. 1996. Transport characterization of hydrogel matrices for cell encapsulation. Biotechnol Bioeng 50:365-373.
14. Meli L, Jordan ET, Clark DS, Linhardt RJ, Dordick JS. 2012. Influence of a three-dimensional, microarray environment on human cell culture in drug screening systems. Biomaterials 33:9087-9096.
15. Mickel W, Munster S, Jawerth LM, Vader DA, Weitz DA, Sheppard AP, Mecke K, Fabry B, Schroder-Turk GE. 2008. Robust pore size analysis of filamentous networks from three-dimensional confocal microscopy. Biophys J 95(12):6072-6080.
16. Mu C, Li D, Lin W, Ding Y, Zhang G. 2007. Temperature induced denaturation of collagen in acidic solution. Biopolymers 86(4):282-287.
17. Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, Hoff B, VanHandel M, Andes D. 2007. Putative role of β-1, 3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother 51(2):510-520.
18. Odabasi Z, Paetznickz V, Rex JH, Ostrosky-Zeichner L. 2007. Effects of serum on in vitro susceptibility testing of echinocandins. Antimicrob Agents Chemother 51(11):4214-4216.
19. Ogston AG, Preston BN, Wells JD. 1973. On the transport of compact particles through solutions of chain-polymers. Proc R Soc Lond A 333:297-316.
20. Paderu P, Garcia-Effron G, Balashov S, Delmas G, Park S, Perlin DS. 2007. Serum differentially alters the antifungal properties of echinocandin drugs. Antimicrob Agents Chemother 51(6):2253-2256.
21. Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45(9):2475-2479.
22. Ramage G, VandeWalle K, Bachmann SP, Wickes BL, Lopez-Ribot JL. 2002. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 46(11):3634-3636.
23. Ramage G, Martinez JP, Lopez-Ribot JL. 2006. Candida biofilms on implanted biomaterials: A clinically significant problem. FEMS Yeast Res 6(7):979-986.
24. Ramanujan S, Pluen A, McKee TD, Brown EB, Boucher Y, Jain RK. 2002. Diffusion and convection in collagen gels: Implications for transport in the tumor interstitium. Biophys J 83(3):1650-1660.
25. Richards MJ, Edwards JR, Culver DH, Gaynes RP. 1999. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 27(5):887-892.
26. Ritger PL, Peppas NA. 1987. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 5(1):23-36.
27. Smidsrod O, Skjak-Braek G. 1990. Alginate as immobilization matrix for cells. Trends Biotechnol 8(3):71-78.
28. Srinivasan A, Uppuluri P, Lopez-Ribot J, Ramasubramanian AK. 2011. Development of a high-throughput Candida albicans biofilm chip. PLoS ONE 6(4):e19036.
29. Srinivasan A, Lopez-Ribot JL, Ramasubramanian AK. 2012. Candida albicans biofilm chip (CaBChip) for high-throughput antifungal drug screening. J Vis Exp (65):e3845, doi: 10.3791/3845
30. Srinivasan A, Leung KP, Lopez-Ribot JL, Ramasubramanian AK. 2013. High-throughput nano-biofilm microarray for antifungal drug discovery. mBio 4:(4).
31. Tibbitt MW, Anseth KS. 2009. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 103(4):655-663.